NewsBenzingaShareholder Yakira Capital Urges Atrium Therapeutics To Explore Strategic Sale Or Partnerships, Citing 44% Stock Decline, $50M Dilutive Financing Shareholder Yakira Capital Urges Atrium Therapeutics To Explore Strategic Sale Or Partnerships, Citing 44% Stock Decline, $50M Dilutive Financing Benzinga 2026.10.20 12:12 (GMT+0) Open on Benzinga Other news SAP SE 2026 Q3 - Results - Earnings Call Presentation (NYSE:SAP) 2026-10-21 Texas Capital Bancshares, Inc. (TCBI) Q3 2026 Earnings Call Transcript SAP SE (SAP) Q3 2026 Earnings Call Transcript Swell admin key suspected leaked, malicious contract upgrade could threaten ~2,500 ETH NML: A Sold Income CEF Benefiting From America's Energy Boom (NYSE:NML) DeepSeek completes ~100 billion yuan funding round, led by CATL and Tencent
